Prof. Jörg Rademann is a Professor of Pharmaceutical/Medicinal Chemistry at Freie Universität Berlin since 2013. His research group specializes in fragment-based drug discovery and chemical biology , focusing on protein-ligand interactions for disease-related targets in cancer , Alzheimer's , tuberculosis , and viral infections (SARS, Zika, dengue, West Nile). The group integrates synthetic organic chemistry with bioanalytical , biochemical , and biophysical techniques , operating within the Department of Pharmacy at Freie Universität Berlin. B.Sc., M.Sc., and Ph.D. teaching: Inorganic and organic drug chemistry, pharmaceutical analysis Co-initiator of national ChemBioNet for chemical biology collaboration Developed Dynamic Ligation Screening (DLS) for fragment identification Research Interests include: Fragment-based ligand discovery for proteases, phosphatases, and protein-protein interactions Chemical probe development for structural and functional protein studies Solid-phase synthesis of peptides, peptidomimetics, and carbohydrates Multivalent constructs for enhanced binding and pharmacological properties Glycosaminoglycan (GAG) interactions in disease mechanisms Synthetic methodology for C-acylation and phosphorus/sulfur ylides Scientific Awards : Innovation Award in Medicinal Chemistry (GDCh/DPhG) (2002) Thieme Journal Award (2002) DFG Junior Research Group (2002) Landesgraduiertenförderung Baden-Württemberg (1994-97) Rutgers exchange fellowship (1990) Jugend forscht award (1986) Email : joerg.rademann@fu-berlin.de





